Abstract

NFATc1, which is ubiquitous in many cell types, is the master regulator of osteoclastogenesis. However, the molecular mechanisms by which NFATc1 drives its transcriptional program to produce osteoclasts from macrophages (M) remains poorly understood. We performed quantitative PCR (QPCR) arrays and bioinformatic analyses to discover new direct and indirect NFATc1 targets. The results revealed that NFATc1 significantly modified the expression of 55 genes in untransfected cells and 31 genes after NFATc1-knockdown (≥2). Among them, we focused on 19 common genes that showed changes in the PCR arrays between the two groups of cells. Gene Ontology (GO) demonstrated that genes related to cell differentiation and the development process were significantly (p > 0.05) affected by NFATc1-knockdown. Among all the genes analyzed, we focused on GATA2, which was up-regulated in NFATc1-knockdown cells, while its expression was reduced after NFATc1 rescue. Thus, we suggest GATA2 as a new target of NFATc1. Ingenuity Pathway Analysis (IPA) identified up-regulated GATA2 and the STAT family members as principal nodes involved in cell differentiation. Mechanistically, we demonstrated that STAT6 was activated in parallel with GATA2 in NFATc1-knockdown cells. We suggest an alternative pathway for macrophage differentiation in the absence of NFATc1 due to the GATA2 transcription factor.

Highlights

  • It is well established that pluripotency of the cells is maintained as a consequence of the balance of different lineage-specifying forces

  • Osteoclastogenesis depends on two main cytokines, the M-CSF and the receptor activator of nuclear factor-κB ligand (RANKL), which are essential for osteoclast lifespan and function through their receptors, the colony-stimulating factor receptor (c-fms) and receptor activator of nuclear factor-κB (RANK), respectively [6,7,8]

  • To follow osteoclastogenesis in vitro, RAW 264.7 cells were stimulated with RANKL and observed for the formation of multinucleated cells

Read more

Summary

Introduction

It is well established that pluripotency of the cells is maintained as a consequence of the balance of different lineage-specifying forces. Differentiation of hematopoietic progenitors into distinct lineages depends on the activation of specific and tightly regulated transcription factors. Osteoclastogenesis depends on two main cytokines, the M-CSF and the receptor activator of nuclear factor-κB ligand (RANKL), which are essential for osteoclast lifespan and function through their receptors, the colony-stimulating factor receptor (c-fms) and receptor activator of nuclear factor-κB (RANK), respectively [6,7,8]. Osteoclasts share with macrophages a trait of differentiation due to the activation of many signalling pathways and transcription factors as a consequence of the same cytokine stimulation (M-CSF). NFATc1 is widely expressed in different cell types and is essential for the development of many tissues [12] It is considered the master regulator of osteoclastogenesis, it is not clear how the ubiquitous NFATc1 can direct an osteoclast-specific transcription program. We hypothesize that these two transcription factors could be involved in the specification of different cell lineages

Cell Culture and Osteoclastogenesis In Vitro
RNA Extraction and cDNA Synthesis
RT2 Profiler PCR Array Analysis
Western Blot
GO and Pathway Analysis
Effects of NFATc1 Loss on Differentiation into Osteoclasts
Identification of Common and Unique Genes Targeted by NFATc1
GATA2 as a New Target of NFATc1
Protein network analysis using
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call